Bringing the fundamentals into focus…
Back to Crinetics Pharmaceuticals Inc
How Crinetics Pharmaceuticals Inc stacks up
CRNX · against 172 other Healthcare companies of similar size
Overall
51/ 100
Below the middle of the pack.
Ranked #116 of 173 · scores higher than 33% of peers
Bars: peers in each 10-point band of the overall score45 peers with an overall score of 50–59, including CRNX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CRNX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 2 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 3 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 4 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 4 | 9.0B USD | 78 | 50 | 80 | 94 | 0 / 2 | |
| 111 | 5.1B USD | 52 | 42 | 85 | 47 | 2 / 2 | |
| 111 | 4.8B USD | 52 | 69 | 51 | 66 | 2 / 2 | |
| 111 | 9.7B AUD (≈$6.4B) | 52 | 84 | 40 | 58 | 2 / 2 | |
| 116 | 8.9B USD | 51 | 32 | 54 | 48 | 0 / 2 | |
| 116 | 9.0B USD | 51 | 8 | 95 | 2 | 0 / 2 | |
| 118 | 1.42T JPY (≈$9.6B) | 50 | 65 | 34 | 54 | 1 / 2 | |
| 118 | 5.3B USD | 50 | 45 | 66 | 31 | 1 / 2 | |
| 118 | 8.8B USD | 50 | 33 | — | 24 | 0 / 2 | |
| 121 | 4.7B GBP (≈$6.1B) | 49 | 62 | 43 | 74 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score